Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?
For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable effects [...].
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-04-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://btvb.org/btvb/article/view/22 |
| _version_ | 1797835207758315520 |
|---|---|
| author | Marco P. Donadini Walter Ageno |
| author_facet | Marco P. Donadini Walter Ageno |
| author_sort | Marco P. Donadini |
| collection | DOAJ |
| description |
For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable effects [...].
|
| first_indexed | 2024-04-09T14:49:28Z |
| format | Article |
| id | doaj.art-fdd64e8267fb48d2b339a5e27346af5f |
| institution | Directory Open Access Journal |
| issn | 2785-5309 |
| language | English |
| last_indexed | 2024-04-09T14:49:28Z |
| publishDate | 2022-04-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Bleeding, Thrombosis and Vascular Biology |
| spelling | doaj.art-fdd64e8267fb48d2b339a5e27346af5f2023-05-02T10:09:36ZengPAGEPress PublicationsBleeding, Thrombosis and Vascular Biology2785-53092022-04-011110.4081/btvb.2022.22Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?Marco P. Donadini0Walter Ageno1Research Center on Thromboembolic Diseases and Antithrombotic Therapies, Department of Medicine and Surgery, University of Insubria, Varese; Thrombosis and Hemostasis Center, Ospedale di Circolo e Fondazione Macchi, Azienda Socio-Sanitaria territoriale dei Sette Laghi, VareseResearch Center on Thromboembolic Diseases and Antithrombotic Therapies, Department of Medicine and Surgery, University of Insubria, Varese; Thrombosis and Hemostasis Center, Ospedale di Circolo e Fondazione Macchi, Azienda Socio-Sanitaria territoriale dei Sette Laghi, Varese For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable effects [...]. https://btvb.org/btvb/article/view/22MilvexianAnti-XI agentsVenous thromboembolism |
| spellingShingle | Marco P. Donadini Walter Ageno Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? Bleeding, Thrombosis and Vascular Biology Milvexian Anti-XI agents Venous thromboembolism |
| title | Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? |
| title_full | Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? |
| title_fullStr | Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? |
| title_full_unstemmed | Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? |
| title_short | Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? |
| title_sort | milvexian and other drugs targeting factor xi a new era of anticoagulation |
| topic | Milvexian Anti-XI agents Venous thromboembolism |
| url | https://btvb.org/btvb/article/view/22 |
| work_keys_str_mv | AT marcopdonadini milvexianandotherdrugstargetingfactorxianeweraofanticoagulation AT walterageno milvexianandotherdrugstargetingfactorxianeweraofanticoagulation |